CSHL researchers reveal MED12 as key player in basal-like pancreatic cancer

FHS
June 17, 2024
10:57 am

Things aren’t always as they seem. Take pancreatic cancer, for example. In up to one in 10 cases, researchers have documented a peculiar characteristic.

Awakn Life Sciences Announces Closing of the Second Tranche and Upsizing of Previously Announced Private Placement | Psychedelic Finance

Toronto, Ontario–(Newsfile Corp. – June 15, 2023) – Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (the “Company“), a clinical-stage biotechnology company developing

June 21, 2023

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024 – Biotech Investments

Issuer: Immunic, Inc. / Key word(s): Conference 29.02.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic Presents Data

March 1, 2024

Key kinase involved in cell division linked to abnormal blood vessel growth in genetic disorder

Inhibition of CDK6 may prevent arteriovenous malformations in hereditary hemorrhagic telangiectasia by regulating endothelial cell cycle progression.

November 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.